Dry eye treatment IPL system eye-light®

table-top

Overview
eye-light® is Espansione Group’s flagship light-based medical device for ophthalmic care. Designed to support clinicians in managing ocular surface and retinal conditions, eye-light® integrates clinical evidence, scalable innovation and proven technologies (LM™ LLLT photobiomodulation and OPE™ IPL) to deliver non-invasive, light-based treatments for both anterior and posterior segment conditions within a single platform.

What’s new / Evolution
The latest evolution of eye-light® introduces a new modular, software-driven architecture developed specifically for ophthalmic workflows and clinical environments, reinforcing clinical capabilities across ocular surface disease management, surgical outcome optimization and retinal care through photobiomodulation.

Key features

• Dual-therapy platform combining LM™ LLLT and OPE™ IPL for comprehensive anterior and posterior segment care
• Modular software architecture enabling expandable treatment capabilities without replacing the device
• Up to nine treatment protocols for anterior and posterior care, expandable anytime
• Advanced operational intelligence including real-time system checks, smart alerts and on-screen guidance for accurate treatment setup
• Non-invasive, light-based therapies delivered within a single platform

Next-generation hardware

• Intuitive 7” touchscreen interface
• Powerful CPU for fast system interaction
• Stable Linux-based operating system
• Designed for daily clinical use, long-term reliability and operational efficiency

Technologies
LM™ LLLT – Photobiomodulation
Patented low-level light therapy using multiple wavelengths (Red, Blue and Yellow) each designed to elicit specific cellular responses. LM™ LLLT is used across anterior and posterior indications to modulate inflammation and support cellular metabolism.

OPE™ IPL – Intense Pulsed Light
Patented, software-controlled IPL technology delivering calibrated thermal impulses with high safety standards. OPE™ IPL is used exclusively for the treatment of selected anterior segment conditions, delivering gentle, non-invasive pulses targeting the lower eyelid to boost circulation and support anti-inflammatory activity.

Clinical applications

• Ocular surface disease management
• Dry eye disease (DED) and meibomian gland dysfunction (MGD)
• Tear film stabilization
• Pre- and post-surgical optimization
• Retinal care through photobiomodulation to support retinal function and preserve vision
• Support in slowing progression of dry AMD (AREDS 2–3) via photobiomodulation

Scientific support

• LM™ LLLT is recognized by TFOS DEWS III as a management tool for DED and ocular surface disease
• Multicentric clinical research programs (LightWave I & II) explore photobiomodulation for dry AMD (AREDS 2–3)

Caractéristiques / spécifications techniques

• Brand: Espansione Group
• Platform type: Dual-therapy, modular light-based medical device for ophthalmology
• Primary technologies: LM™ LLLT (multi-wavelength photobiomodulation) and OPE™ IPL (software-controlled IPL)
• Treatment protocols: Up to nine modular, software-driven protocols for anterior and posterior segment care; expandable without hardware replacement
• Interface: 7-inch touchscreen
• Operating system: Linux-based
• Processing: Powerful CPU for fast system interaction
• Indications: Ocular surface disease, DED/MGD, tear film stabilization, pre/post surgical optimization, retinal photobiomodulation for dAMD support (AREDS 2–3)
• OPE™ IPL availability: Exclusively for selected anterior segment conditions
• Design priorities: Non-invasive treatments, daily clinical use, long-term reliability and operational efficiency